A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes

Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: NNC0519-0130; Drug: Placebo; Drug: Trizepatide Sponsors: Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials